|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Laboratory for Experimental Nuclear Medicine at Harvard Medical School |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 | ||
|
|
| ||
|
Laboratory for Experimental Nuclear Medicine at Harvard Medical School |
|
|
|
|
|
|
The section of Radiobiology and Experimental Radionuclide Therapy is involved with the biophysical consequences of radioactive decay and its application to cancer therapy. Members examine cell survival, neoplastic transformation, and DNA damage resulting from the dense ionization produced by cascades of Auger electrons and alpha particles. The laboratory is also involved with the development of radionuclide carrier systems suitable for the specific delivery of diagnostic and therapeutic radioactive moieties to solid tumors.
|
|
|
|
|
|
For more information about the SPECT Research Facility and the microSPECT Instrument available at Harvard Medical School please visit their website .
|
|
|
|
|
|
